Drug-induced motor complications in dopa-responsive dystonia: Implications for the pathogenesis of dyskinesias and motor fluctuations

Clinical Neuropharmacology

Volumn 22, Issue 4, 1999, Pages 216-219

  De La Fuente Fernández, Raúl ^a,b  

^a Centro de Investigacion Biomedica EuroEspes   (Spain)

^b Universidad de La Coruña   (Spain)

Author keywords

Doparesponsive dystonia; Drug induced dyskinesias; Motor fluctuations; Parkinson's disease

Indexed keywords

APOMORPHINE; CARBIDOPA PLUS LEVODOPA; DOMPERIDONE; DOPAMINE; DOPAMINE RECEPTOR; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; LEVODOPA; METOCLOPRAMIDE; PERPHENAZINE; SULPIRIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; DYSKINESIA; DYSTONIA; FEMALE; GENE MUTATION; HUMAN; MALE; MOTOR DYSFUNCTION; NIGRONEOSTRIATAL SYSTEM; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; CARBIDOPA; DOPAMINE AGENTS; DYSKINESIA, DRUG-INDUCED; DYSTONIA; FEMALE; GTP CYCLOHYDROLASE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; MOTOR SKILLS DISORDERS; PARKINSON DISEASE;

EID: 0343986283     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Rajput AH, Gibb WRG, Zhong XH, et al. Dopa-responsive dystonia: pathological and biochemical observations in a case. Ann Neurol 1994:35:396-402.
2. Snow BJ, Nygaard TG, Takahashi H, Calne DB. Positron emission tomographic studies of dopa-responsive dystonia and early-onset idiopathic parkinsonism. Ann Neurol 1993;34:733-8.
3. Nygaard TG, Marsden CD, Fahn S. Dopa-responsive dystonia: long-term treatment response and prognosis. Neurology 1991;41: 174-81.
4. Calne DB, de la Fuente-Fernández R, Kishore A. Contributions of positron emission tomography to elucidating the pathogenesis of idiopathic parkinsonism and dopa responsive dystonia. J Neural Transm 1997;50(suppl):47-52.
5. Calne DB, Nygaard TG, Snow BJ. The distinction between early onset idiopathic parkinsonism (juvenile Parkinson's disease) and dopa-responsive dystonia (hereditary progressive dystonia, Segawa dystonia). In: Segawa M, ed. Hereditary progressive dystonia with marked diurnal fluctuation. Carnforth, UK: Parthenon; 1993:215-25.
6. Ichinose H, Ohye T, Takahashi E, et al. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nature Genet 1994;8:236-42.
7. Fahn S, Elton RL, and members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent developments in Parkinson's disease. Volume II. Florham Park, NJ: MacMillan Healthcare Information; 1987:153-63.
8. Hughes A, Lees AJ, Stern G. The apomorphine test for dopaminergic responsiveness in parkinsonian syndromes. Lancet 1990;336: 32-4.
9. Beyer K, Lao-Villadóniga JI, Vecino-Bilbao B, Cacabelos R, de la Fuente-Fernández R. A novel point mutation in the GTP cyclohydrolase I gene in a Spanish family with hereditary progressive and dopa responsive dystonia [letter]. J Neurol Neurosurg Psychiatry 1997;62:420-1.
10. de la Fuente-Fernandez R. Mutations in GTP-cyclohydrolase I gene and vitiligo [letter]. Lancet 1997;350:640.
11. de la Fuente-Fernandez R. Tardive dyskinesia in dopa-responsive dystonia: a reappraisal of the dopamine hypothesis of tardive dyskinesia. Neurology 1998;50:1134-5.
12. Juncos JL, Engber TM, Raisman R, et al. Continuous and intermittent levodopa differentially affect basal ganglia function. Ann Neurol 1989;25:473-8.
13. 11C]-raclopride and positron-emission tomography. Neurology 1998;50:1028-32.
14. Kishore A, de la Fuente-Fernández R, Snow BJ, et al. Levodopainduced dyskinesias in Idiopathic Parkinsonism (IP): a simultaneous PET study of dopamine D1 and D2 receptors [abstract]. Neurology 1997;48:A327.
15. 2 receptor supersensitivity in the striatum of patients with early Parkinson's disease. Mov Disord 1990;5:55-9.
16. 2 receptor changes during the progression of early Parkinson's disease. Mov Disord 1993;8:134-8.
17. Sawle GV, Playford ED, Brooks DJ, Quinn N, Frackowiack RSJ. Asymmetrical pre-synaptic and post-synaptic changes in the striatal dopamine projection in dopa-naive parkinsonism. Brain 1993;116: 853-67.
18. 2-receptors. Neurology 1994;44:1325-9.
19. Jankovic J. Tardive syndromes and other drug-induced movement disorders. Clin Neuropharmacol 1995;18:197-214.
20. Fabbrini G, Mouradian MM, Juncos JL, Schlegel J, Mohr E, Chase TN. Motor fluctuations in Parkinson's disease: centralpathophysiological mechanisms, part I. Ann Neurol 1988;24: 366-71.
21. Bravi D, Mouradian MM, Roberts JW, Davis TL, Sohn YH, Chase TN. Wearing-off fluctuations in Parkinson's disease: contribution of postsynaptic mechanisms. Ann Neurol 1994;36:27-31.
22. de la Fuente-Fernández R, Kishore A, Snow BJ, et al. Dopamine D1 and D2 receptors and motor fluctuations in Idiopathic Parkinsonism (IP): a simultaneous PET study [abstract]. Neurology 1997;48: A208.
23. de la Fuente-Fernández R, Vingerhoets FJG, Kishore A, Schulzer M, Mak E, Calne DB. Motor fluctuations in Idiopathic Parkinsonism are unrelated to the severity of the nigrostriatal damage: a fluorodopa PET study [abstract]. Neurology 1996;46:A453.
24. Leenders KL, Palmer AJ, Quinn N, et al. Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography. J Neural Neurosurg Psychiatry 1986;49: 853-60.
25. Calne DB, Zigmond MJ. Compensatory mechanisms in degenerative neurologic diseases. Insights from parkinsonism. Arch Neurol 1991;48:361-3.